"Tal recently showed that synchronized lysis technology can be used to deliver an immunotherapy to tumors in mice. To my knowledge, they are the first to show that bacterial drug production and delivery within a treated tumor can modify the immune system to attack untreated tumors. The results are fascinating. They also highlight how important it is for us to figure out how to keep the lysis circuit running as long as possible," said Hasty.
UTal usanda kukhombisa ukuthi ubuchwepheshe belayisi obuvumelanisiwe bungasetshenziswa ukuletha ukwelashwa kwamasotsha omzimba kuyizigaxa kumagundane. Ngokwazi kwami, bangabokuqala ukukhombisa ukuthi ukukhiqizwa kwezidakamizwa ezibangelwa amagciwane kanye nokulethwa ngaphakathi kwessigaxa esiphathwayo kungaguqula amasosha omzimba ahlasele izicubu ezingalashwa. Imiphumela iyajabulisa. Baphinde bagqamise nokuthi kubaluleke kangakanani ukuthi sazi ukuthi singagcina kanjani isekethe lelayisi elisebenza isikhathi eside uma kungenzeka, "kusho uHasty.